Related Experiment Video

Updated: May 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Pertussis: what the pediatric infectious disease specialist should know

Ulrich Heininger1

  • 1Division of Pediatric Infectious Diseases, University Children's Hospital Basel, Switzerland.

The Pediatric Infectious Disease Journal
|January 6, 2012
PubMed

Insights

Pertussis, a highly contagious bacterial illness, causes severe coughing fits. Prompt diagnosis and antibiotic treatment are crucial for controlling pertussis spread, alongside high vaccination rates.

Area of Science:

  • Bacteriology
  • Infectious Diseases
  • Vaccinology

Background:

  • Pertussis is a highly transmissible bacterial respiratory infection endemic in all populations.
  • Characterized by severe coughing, it affects all age groups and can lead to outbreaks.
  • Current control relies on vaccination, but challenges remain.

Purpose of the Study:

  • To summarize the epidemiology, diagnosis, treatment, and control of pertussis.
  • To highlight the importance of prompt intervention in managing pertussis outbreaks.
  • To underscore the need for improved pertussis vaccines.

Main Methods:

  • Review of pertussis transmission dynamics.
  • Analysis of diagnostic methods including PCR and serology.
  • Evaluation of current acellular vaccine efficacy and limitations.

Main Results:

  • Pertussis spreads efficiently via droplets, necessitating rapid diagnosis and treatment.
  • Clinical suspicion followed by laboratory confirmation is key for diagnosis.
  • Acellular vaccines offer partial control but require high coverage and boosters.

Conclusions:

  • Effective pertussis management requires prompt antibiotic treatment to prevent transmission.
  • High immunization coverage and lifelong boosters are essential for controlling pertussis.
  • Development of new, more efficacious pertussis vaccines is warranted.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...